annals of the rheumatic diseases

biomedical materials (bristol, england)

genetics, selection, evolution : gse

turkish journal of physical medicine and rehabilitation

archives of rheumatology

[1] Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in Patients With Ankylosing Spondylitis: A Validation and Reliability Study.

[2] Resorbable PCEC/gelatin-bismuth doped bioglass-graphene oxide bilayer membranes for guided bone regeneration.

[3] The relationship of serum vitamin D receptor levels with disease activity and clinical parameters in patients with ankylosing spondylitis.

[4] Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.

[5] Evolutionary history of Mexican domesticated and wild Meleagris gallopavo.

[6] Association of Regional Bone Synthetic Activities of Vertebral Corners and Vertebral Bodies Quantified Using 18F-Fluoride Positron Emission Tomography with Bone Mineral Density on Dual Energy X-ray Absorptiometry in Patients with Ankylosing Spondylitis

[7] comparative efficacy and safety of infliximab biosimilar (bcd-055) and innovator infliximab in patients with ankylosing spondylitis (results of international, multiple-center, double-blind phase i and phase iii clinical studies)

[8] a new natural lactone from <em>dimocarpus</em> <em>longan</em> lour. seeds

[9] unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study

[10] certolizumab pegol in the treatment of spondyloarthritis

[11] angiopathy in ankylosing spondylitis

[12] the economic burden of musculoskeletal disorders on the italian social security pension system estimated by a monte carlo simulation

[13] acute anterior uveitis as the initial presentation of alkaptonuria

[14] Temporomandibular joint ankylosis in ankylosing spondylitis: A case report and review of literature

[15] Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in Patients With Ankylosing Spondylitis: A Validation and Reliability Study.

[16] Screening of underlying genetic biomarkers for ankylosing spondylitis.

[17] Factors associated with depressive symptoms in patients with ankylosing spondylitis in Northern Taiwan.

[18] Low gluten starch diet and nutritional supplementation in two cases of ankylosing spondylitis

[19] The relationship of serum vitamin D receptor levels with disease activity and clinical parameters in patients with ankylosing spondylitis.

[20] A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin

[21] Carbohydrate metabolism disorders in patients with rheumatoid arthritis and ankylosing spondylitis – impact of treatment

[22] Association of Regional Bone Synthetic Activities of Vertebral Corners and Vertebral Bodies Quantified Using 18F-Fluoride Positron Emission Tomography with Bone Mineral Density on Dual Energy X-ray Absorptiometry in Patients with Ankylosing Spondylitis

[23] comparative efficacy and safety of infliximab biosimilar (bcd-055) and innovator infliximab in patients with ankylosing spondylitis (results of international, multiple-center, double-blind phase i and phase iii clinical studies)

[24] low body mass index and blood loss in primary total hip arthroplasty: results from 236 consecutive ankylosing spondylitis patients

[25] patients with ankylosing spondylitis and low disease activity because of anti-tnf-alpha therapy have higher trail levels than controls: a potential compensatory effect

[26] serum vitamin d and pyridinoline cross-linked carboxyterminal telopeptide of type i collagen in patients with ankylosing spondylitis

[27] unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study

[28] long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis

[29] igf-1 and adma levels are inversely correlated in nondiabetic ankylosing spondylitis patients undergoing anti-tnf-alpha therapy

[30] angiopathy in ankylosing spondylitis

[31] immunogenetic study in chinese population with ankylosing spondylitis: are there specific genes recently disclosed?

[32] surgical management of temporomandibular joint ankylosis in ankylosing spondylitis

[33] comparison of deep tissue massage and therapeutic massage for lower back pain, disease activity, and functional capacity of ankylosing spondylitis patients: a randomized clinical pilot study

[34] health care costs associated with ankylosing spondylitis in turkey: an analysis from nationwide real-world data

[35] [Female ankylosing spondylitis].

[36] [Female ankylosing spondylitis]

[37] Anti-TNF-α Treatment Response in Ankylosing Spondylitis Depends on Gut Microbiota